← 產業報告目錄
Anal Cancer Market, By Drug Type(Fluorouracil, Cisplatin, Carboplatin, Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)), By Cancer Type (Carcinoma In-situ, Squamous Cell Carcinoma, Melanoma, Adenocarcinoma, Basal Cell Carcinoma), By Treatment Type (Chemotherapy, Surgery, Radiation Therapy, Immunotherapy), By Distribution Channel (Hospitals & Clinics, Research & Academic Institutes, Long-term Care Centers, Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版商 Coherent Market Insights出版日期 2026-07-01頁數 257報告編號 CMR-045d63a0a7
授權報價
| Single User Price | $4,500 USD |
| Site License Price | $7,000 USD |
| Enterprisewide Price (Global Site License) | $10,000 USD |
報告摘要
Anal cancer is a rare type of cancer in the anal canal. The anal canal is a short tube, about 1-1½ inches long between anal opening and rectum through which stool passes out of the human body. Some of the symptoms associated with anal cancer include anal or rectum bleeding, lump near anus, pain around the anus, itching in the anus, discharge from the anus, changes in bowel habits, and others. Anal cancer can be caused due to a number of risk factors such as human papillomavirus (HPV) infection, having multiple sexual partners, indulging in receptive anal intercourse (anal sex), excessive smoking, medical history of vaginal, cervical or vulvar cancers. Moreover, immune-compromised patients who have a disease or condition which causes weakening of immune system such as organ transplant, human immunodeficiency virus (HIV), and others.
Market Dynamics
The increasing incidence of anal cancer and sexually transmitted diseases, rising research and development activities for the development of novel therapeutics for the treatment of anal cancer, and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, are the major factors that are expected to drive growth of the global anal cancer market over the forecast period.
For instance, according to data provided by the Cancer Research U.K. in 2018, around 1,500 new cases of anal cancer are reported every year in the U.K, i.e. four new anal cancer cases daily. The same source also states that the incidence rate of anal cancer in the U.K. is highest in elderly people of age 90 and above.
Key features of the study
• This report provides in-depth analysis of the global anal cancer market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anal cancer market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Advaxis, Inc., ORYX GmbH and Co. KG, Eli Lilly and Company, Merck KGaA, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Onconova Therapeutics, BioMimetix JV, LLC, Bayer AG, Spectrum Pharmaceuticals Inc., Global BioPharma Inc., Amgen Inc., Atara Biotherapeutics Inc., ISA Pharmaceuticals, Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Sanofi, and Johnson & Johnson Private Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global anal cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anal cancer market
Market Segmentation
• By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Fluorouracil
o Cisplatin
o Carboplatin
o Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
• By Cancer Type Insights (Revenue, USD Mn, 2021 - 2033)
o Carcinoma In-situ
o Squamous Cell Carcinoma
o Melanoma
o Adenocarcinoma
o Basal Cell Carcinoma
• By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
o Chemotherapy
o Surgery
o Radiation Therapy
o Immunotherapy
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals & Clinics
o Research & Academic Institutes
o Long-term Care Centers
o Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players
o Advaxis, Inc.
o ORYX GmbH and Co. KG
o Eli Lilly and Company
o Merck KGaA
o Hoffmann-La Roche Ltd.
o GlaxoSmithKline plc
o Onconova Therapeutics
o BioMimetix JV, LLC
o Bayer AG
o Spectrum Pharmaceuticals Inc.
o Global BioPharma Inc.
o Amgen Inc.
o Atara Biotherapeutics Inc.
o ISA Pharmaceuticals
o Takeda Pharmaceutical Company Limited
o Ono Pharmaceutical Co., Ltd.
o Sun Pharmaceutical Industries Ltd.
o Bristol-Myers Squibb Company
o Novartis AG
o Pfizer Inc.
o Sanofi
o Johnson & Johnson Private Limited
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Cancer Type
Market Snippet, By Treatment Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o PEST Analysis
o Regulatory Scenario
o Market Trends
o Key Highlights
o Reimbursement Scenario
o Mergers & Acquisitions
4. Global Anal Cancer Market, By Drug Type, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Fluorouracil
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Cisplatin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Carboplatin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
5. Global Anal Cancer Market, By Cancer Type, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Carcinoma In-situ
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Squamous Cell Carcinoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Melanoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Adenocarcinoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Basal Cell Carcinoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
6. Global Anal Cancer Market, By Treatment Type, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Radiation Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
7. Global Anal Cancer Market, By Distribution Channel, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Research & Academic Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Long-term Care Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
8. Global Anal Cancer Market, By Region, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Cancer Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Region/Country, 2021 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Advaxis, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
ORYX GmbH and Co. KG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck KGaA
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
F. Hoffmann-La Roche Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Onconova Therapeutics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
BioMimetix JV, LLC
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bayer AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Spectrum Pharmaceuticals Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Global BioPharma Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amgen Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Atara Biotherapeutics Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
ISA Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Takeda Pharmaceutical Company Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Ono Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sun Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bristol-Myers Squibb Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson & Johnson Private Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About us and Sales Contact
圖表清單 List of Tables & Figures
NA
NA
提及公司
o AdvaxisInc.o ORYX GmbH and Co. KGo Eli Lilly and Companyo Merck KGaAo Hoffmann-La Roche Ltd.o GlaxoSmithKline plco Onconova Therapeuticso BioMimetix JVLLCo Bayer AGo Spectrum Pharmaceuticals Inc.o Global BioPharma Inc.o Amgen Inc.o Atara Biotherapeutics Inc.o ISA Pharmaceuticalso Takeda Pharmaceutical Company Limitedo Ono Pharmaceutical Co.Ltd.o Sun Pharmaceutical Industries Ltd.o Bristol-Myers Squibb Companyo Novartis AGo Pfizer Inc.o Sanofio Johnson & Johnson Private Limited
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們